Get startedLog in
    Picture of Basilea Pharmaceutica AG, Allschwil logo

    BSLN — Basilea Pharmaceutica AG, Allschwil News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    All News

    Brief: Basilea Pharmaceutica Announces Agreement With Prokaryotics

    Picture of Basilea Pharmaceutica AG, Allschwil logoBasilea Pharmaceutica AG, Allschwil
    07/01/2026 07:37
    Jan 7 (Reuters) - Basilea Pharmaceutica AG Allschwil BSLN.S:

BASILEA AND PROKARYOTICS ENTER COLLABORATION TO DEVELOP A NOVEL BROAD-SPECTRUM ANTIFUNGAL FOR THE TREATMENT OF SEVERE INVASIVE INFECTIONS

TO MAKE UNDISCLOSED UPFRONT PAYMENT, ALONG WITH NEAR-TERM MILESTONE PAYMENTS TO PROKARYOTICS

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Basilea Pharmaceutica AG, Allschwil

    See all news